Fibrinogen beta variants confer protection against coronary artery disease in a Greek case-control study

• Main Authors: Zakopoulos Nikolaos (Author), Richter Dimitrios (Author), Papamikos Vassileios (Author), Kolovou Genovefa (Author), Fili Panagiota (Author), Peppes Vassileios (Author), Suhorutšenko Julia (Author), Nikopensius Tiit (Author), Theodoraki Eirini V (Author), Krjutškov Kaarel (Author), Metspalu Andres (Author), Dedoussis George V (Author)
• Format: Book
• Published: BMC, 2010-02-01T00:00:00Z.
• Subjects: article
• Online Access: Connect to this object online.

<p>Abstract</p> <p>Background</p> <p>Although plasma fibrinogen levels are related to cardiovascular risk, data regarding the role of fibrinogen genetic variation in myocardial infarction (MI) or coronary artery disease (CAD) etiology remain inconsistent. The purpose of...